Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

A significant number of Nigerian women struggling with infertility have Polycystic Ovary Syndrome, with the exact percentage varying based on the diagnostic criteria used.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

PCOS affects many aspects of health, not just fertility, and needs comprehensive treatment.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Low HDL-C, uric acid, and 25-hydroxyvitamin D are risk factors for early-onset male hair loss.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

The finasteride patch effectively treats hair loss by enhancing skin absorption.

Omega-6 and LDL cholesterol increase the risk of hair loss.

The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

Levothyroxine is less effective in men with early-onset male-pattern baldness.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Skin changes in women with PCOS are mainly due to hormonal imbalances.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.